If you think you have symptoms of PTSD or depression, talk with your healthcare professional. They can help you begin the process of finding an appropriate treatment plan for your symptoms.

Repetitive transcranial magnetic stimulation applied to the left side of the dorsolateral prefrontal cortex (an area at the upper front area of the brain) is approved for treatment of depression in ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

There are several lupus treatment options. However, there is no “best" treatment for lupus because each person living with the condition will have their own needs and goals for managing it. Lupus ...

Now a sub-study shows that there is also ... Sleeping for 2: Insomnia Therapy Reduces Postpartum Depression, Study Shows Oct. 31, 2024 — CBT for insomnia significantly reduces postpartum ...

A new study highlights the link between inflammation and depression, challenging traditional neurotransmitter-focused ...

“The best way to determine the right acne treatment plan is to see a dermatology provider,” Julie C. Harper, MD, a board certified dermatologist and clinical associate professor of dermatology ...

We never left a feature untouched in our reviews of the best PDF editor. From OCR and eSignatures to cloud storage services, we’ve tested them all – so we know what makes the best choice for ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Among male footballers, he also has the most international goals of all time, as part of his enduring pursuit of titles and records. Argentina and Inter Miami star Lionel Messi — who is nearly ...

Demand for mental health services exceeds available resources globally, and access to diagnosis and evidence-based treatment ...

AbbVie (NYSE:ABBV) shares dropped about 11% after its mid-stage trials investigating emraclidine as an oral monotherapy treatment for adults with schizophrenia experiencing acute exacerbation of ...